(Q43105424)

14 November 2017

title

Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes (English)

1 reference

14 November 2017

1 reference

1 reference

1 reference

1 reference

4

1 reference

14 November 2017

6

1 reference

14 November 2017

8

1 reference

14 November 2017

author name string

Kristina M Utzschneider

1

1 reference

14 November 2017

Anne Van de Lagemaat

2

1 reference

14 November 2017

Mirjam V Faulenbach

3

1 reference

14 November 2017

Darcy B Carr

5

1 reference

14 November 2017

Wilfred Y Fujimoto

7

1 reference

14 November 2017

publication date

8 April 2010

1 reference

14 November 2017

1 reference

14 November 2017

volume

18

1 reference

14 November 2017

issue

9

1 reference

14 November 2017

page(s)

1781-1787

1 reference

Can we identify metabolically healthy but obese individuals (MHO)?

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

The GENNID Study. A resource for mapping the genes that cause NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Abdominal and total adiposity and risk of coronary heart disease in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

An update on type 2 diabetes in youth from the National Diabetes Education Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Development of Health-Related Waist Circumference Thresholds Within BMI Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Cardiovascular morbidity and mortality associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Abdominal adiposity and coronary heart disease in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Distribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

inferred from DOI database lookup

7 January 2021

based on heuristic

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

inferred from DOI database lookup

7 January 2021

based on heuristic

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.77

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2010.77

1 reference

14 November 2017

1 reference